Document Detail


Effects of cognitive impairment on substance abuse treatment attendance: predictive validation of a brief cognitive screening measure.
MedLine Citation:
PMID:  22443860     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND AND OBJECTIVES: Neuropsychological impairment among patients with substance use disorders (SUDs) contributes to poorer treatment processes and outcomes. However, neuropsychological assessment is typically not an aspect of patient evaluation in SUD treatment programs because it is prohibitively time and resource consuming. In a previous study, we examined the concurrent validity, classification accuracy, and clinical utility of a brief screening measure, the Montreal Cognitive Assessment (MoCA), in identifying cognitive impairment among SUD patients. To provide further evidence of criterion-related validity, MoCA classification should optimally predict a clinically relevant behavior or outcome among SUD patients. The purpose of this study was to examine the validity of the MoCA in predicting treatment attendance.
METHODS: We compared previously collected clinical assessment data on 60 SUD patients receiving treatment in a program of short duration and high intensity to attendance data obtained via medical chart review.
RESULTS: Though the proportion of therapy sessions attended did not differ between groups, cognitively impaired subjects were significantly less likely than unimpaired subjects to attend all of their group therapy sessions.
CONCLUSION: These results complement our previous findings by providing further evidence of criterion-related validity of the MoCA in predicting a clinically relevant behavior (i.e., perfect attendance) among SUD patients.
SCIENTIFIC SIGNIFICANCE: The capacity of the MoCA to predict a clinically relevant behavior provides support for its validity as a brief cognitive screening measure.
Authors:
Marc L Copersino; David J Schretlen; Garrett M Fitzmaurice; Scott E Lukas; Judith Faberman; Jody Sokoloff; Roger D Weiss
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Validation Studies     Date:  2012-03-26
Journal Detail:
Title:  The American journal of drug and alcohol abuse     Volume:  38     ISSN:  1097-9891     ISO Abbreviation:  Am J Drug Alcohol Abuse     Publication Date:  2012 May 
Date Detail:
Created Date:  2012-04-12     Completed Date:  2012-08-14     Revised Date:  2013-06-26    
Medline Journal Info:
Nlm Unique ID:  7502510     Medline TA:  Am J Drug Alcohol Abuse     Country:  England    
Other Details:
Languages:  eng     Pagination:  246-50     Citation Subset:  IM    
Affiliation:
Division of Alcohol and Drug Abuse, McLean Hospital, Belmont, MA, USA. mcopersino@mclean.harvard.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Aged
Cognition Disorders / complications,  psychology*
Female
Humans
Male
Middle Aged
Neuropsychological Tests / statistics & numerical data
Patient Acceptance of Health Care / psychology*
Predictive Value of Tests
Psychotherapy, Group / methods,  statistics & numerical data*
Substance-Related Disorders / complications,  drug therapy,  psychology*,  therapy
Grant Support
ID/Acronym/Agency:
1K23DA027045/DA/NIDA NIH HHS; 1R03DA024126/DA/NIDA NIH HHS; 5K24DA022288/DA/NIDA NIH HHS; K23 DA027045/DA/NIDA NIH HHS; K24 DA022288/DA/NIDA NIH HHS; R03 DA024126/DA/NIDA NIH HHS
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Theoretical Study of Raman Spectra of Methanol in Aqueous Solutions: Non-Coincident Effect of the CO...
Next Document:  R-SNARE YKT6 Resides in Membrane-Associated Protease-Resistant Protein Particles and Modulates Cell ...